Published in BMJ on June 23, 2009
Measuring low-value care in Medicare. JAMA Intern Med (2014) 3.39
Changes in Low-Value Services in Year 1 of the Medicare Pioneer Accountable Care Organization Program. JAMA Intern Med (2015) 3.01
Treatment failure in osteoporosis. Osteoporos Int (2012) 1.82
Treating osteoporosis. Aust Prescr (2016) 1.59
Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition). J Bone Miner Metab (2012) 1.27
Incidence and Predictors of Repeat Bone Mineral Densitometry: A Longitudinal Cohort Study. J Gen Intern Med (2017) 1.02
Monitoring drug therapy. Br J Clin Pharmacol (2012) 1.02
Effective secondary fracture prevention: implementation of a global benchmarking of clinical quality using the IOF Capture the Fracture® Best Practice Framework tool. Osteoporos Int (2015) 0.98
Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment. J Bone Miner Metab (2010) 0.87
A comparison of case-finding strategies in the UK for the management of hip fractures. Osteoporos Int (2012) 0.81
Understanding Referral Patterns for Bone Mineral Density Testing among Family Physicians: A Qualitative Descriptive Study. J Osteoporos (2016) 0.78
The effect of weight and weight change on the long-term precision of spine and hip DXA measurements. Osteoporos Int (2010) 0.78
Bone mineral density testing: too much of a good thing? Can Fam Physician (2010) 0.78
Monitoring bone mineral density during antiresorptive treatment for osteoporosis. BMJ (2009) 0.76
BMD screening in older women: initial measurement and testing interval. J Bone Miner Res (2012) 0.76
Associations between the 2007 Medicare reimbursement reduction for bone mineral density testing and osteoporosis drug therapy patterns of female Medicare beneficiaries. Patient Prefer Adherence (2014) 0.75
Clinical use of bone turnover markers to monitor pharmacologic fracture prevention therapy. Curr Osteoporos Rep (2012) 0.75
Bisphosphonate therapy: when not to monitor BMD. J Fam Pract (2009) 0.75
Bisphosphonates: forever or 5 years and stop? Can Fam Physician (2015) 0.75
Update in women's health for the general internist. J Gen Intern Med (2010) 0.75
Alendronate and raloxifene therapy in the early period after hip fracture. J Rural Med (2011) 0.75
Should all elderly women receive bisphosphonates to prevent osteoporotic fractures? Can J Hosp Pharm (2012) 0.75
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20
Osteoporosis prevention, diagnosis, and therapy. JAMA (2001) 12.60
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int (2006) 11.05
2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ (2002) 9.89
Measurement error. BMJ (1996) 6.18
Can simple clinical measurements detect patient noncompliance? Hypertension (1981) 3.29
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med (2002) 3.10
Multilevel modelling of medical data. Stat Med (2002) 3.05
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract (2004) 2.69
Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res (2006) 2.67
Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab (2002) 2.15
Requirements for DXA for the management of osteoporosis in Europe. Osteoporos Int (2004) 2.11
Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. Fracture Intervention Trial Research Group. JAMA (2000) 1.79
Design of the Fracture Intervention Trial. Osteoporos Int (1993) 1.53
Antifracture efficacy of antiresorptive agents are related to changes in bone density. J Clin Endocrinol Metab (2000) 1.51
Classification of osteoporosis based on bone mineral densities. J Bone Miner Res (2001) 1.31
Regression to the mean: treatment effect without the intervention. J Eval Clin Pract (2005) 1.28
Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial. Osteoporos Int (2004) 1.07
Single-site vs multisite bone density measurement for fracture prediction. Arch Intern Med (2007) 1.02
How to detect and manage low patient compliance in chronic illness. Geriatrics (1980) 0.99
Mixed models showed no need for initial response monitoring after starting antihypertensive therapy. J Clin Epidemiol (2008) 0.89
Use of randomised trials to decide when to monitor response to new treatment. BMJ (2008) 0.83
Estimating probability of non-response to treatment using mixture distributions. Stat Med (2001) 0.81
Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA (2006) 12.47
A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med (2010) 10.33
Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. Contemp Clin Trials (2005) 9.57
Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol (2008) 7.45
The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol (2005) 7.06
Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ (2011) 6.80
Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54
Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med (2010) 6.47
Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev (2012) 6.38
Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis (2007) 5.84
Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med (2010) 5.60
Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA (2010) 5.20
High-trauma fractures and low bone mineral density in older women and men. JAMA (2007) 5.00
Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care Med (2009) 4.90
BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res (2003) 4.64
Daily activity energy expenditure and mortality among older adults. JAMA (2006) 4.36
Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med (2007) 4.23
Long-term survival of children with end-stage renal disease. N Engl J Med (2004) 4.10
Clinical trials in children. Lancet (2004) 3.97
Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med (2003) 3.80
Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.78
Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus. Ann Intern Med (2006) 3.71
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med (2012) 3.62
Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med (2005) 3.56
Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol (2007) 3.49
Acute rejection, T-cell-depleting antibodies, and cancer after transplantation. Transplantation (2014) 3.40
Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study. Arch Intern Med (2005) 3.39
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials. BMJ (2008) 3.35
Monitoring cholesterol levels: measurement error or true change? Ann Intern Med (2008) 3.35
The number, quality, and coverage of randomized controlled trials in nephrology. J Am Soc Nephrol (2004) 3.30
Diagnostic accuracy of urine dipsticks for detection of albuminuria in the general community. Am J Kidney Dis (2011) 3.29
Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort. Cancer Epidemiol Biomarkers Prev (2005) 3.20
Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med (2008) 3.20
Strategies for increasing recruitment to randomised controlled trials: systematic review. PLoS Med (2010) 3.18
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med (2002) 3.10
Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol (2008) 3.06
Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03
Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr Rev (2005) 3.01
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Preoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axilla. Ann Surg (2011) 2.90
Model of outcomes of screening mammography: information to support informed choices. BMJ (2005) 2.86
A drug burden index to define the functional burden of medications in older people. Arch Intern Med (2007) 2.84
An individual person data meta-analysis of preoperative magnetic resonance imaging and breast cancer recurrence. J Clin Oncol (2014) 2.83
KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int (2009) 2.72
Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med (2015) 2.71
Sydney Breast Imaging Accuracy Study: Comparative sensitivity and specificity of mammography and sonography in young women with symptoms. AJR Am J Roentgenol (2003) 2.63
Cost-effectiveness of bone densitometry followed by treatment of osteoporosis in older men. JAMA (2007) 2.62
Cost-effectiveness of initiating dialysis early: a randomized controlled trial. Am J Kidney Dis (2011) 2.62
When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials? Ann Intern Med (2006) 2.59
Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study. Lancet Oncol (2013) 2.52
Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. J Clin Epidemiol (2008) 2.50
Red flags to screen for malignancy and fracture in patients with low back pain: systematic review. BMJ (2013) 2.50
Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol (2010) 2.43
Relationship of changes in physical activity and mortality among older women. JAMA (2003) 2.42
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database Syst Rev (2014) 2.35
Assessing new biomarkers and predictive models for use in clinical practice: a clinician's guide. Arch Intern Med (2008) 2.35
Screening and follow-up of living kidney donors: a systematic review of clinical practice guidelines. Transplantation (2011) 2.34
Incident heart failure prediction in the elderly: the health ABC heart failure score. Circ Heart Fail (2008) 2.33
Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ (2006) 2.30
Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30
Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: the FLEX trial. J Bone Miner Res (2010) 2.29
Proton pump inhibitors and risk of fractures: a meta-analysis of 11 international studies. Am J Med (2011) 2.27
Parents' attitudes to children's participation in randomized controlled trials. J Pediatr (2003) 2.26
Haemoglobin targets: we were wrong, time to move on. Lancet (2007) 2.26
Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ (2013) 2.25
Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med (2012) 2.24
Role of blood pressure targets and specific antihypertensive agents used to prevent diabetic nephropathy and delay its progression. J Am Soc Nephrol (2006) 2.24
Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol (2013) 2.22
HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev (2013) 2.21
Monitoring in chronic disease: a rational approach. BMJ (2005) 2.20
Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) (2011) 2.18
Antibiotics for acute pyelonephritis in children. Cochrane Database Syst Rev (2014) 2.17
Pharmacological treatment of children with gastro-oesophageal reflux. Cochrane Database Syst Rev (2014) 2.12
Measuring the quality of public open space using Google Earth. Am J Prev Med (2011) 2.11
The burden of urinary incontinence and urinary bother among elderly prostate cancer survivors. Eur Urol (2013) 2.10
Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials. Lancet (2005) 2.09
Association of major and minor ECG abnormalities with coronary heart disease events. JAMA (2012) 2.07
Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. JAMA (2011) 2.04
Enteral vs intravenous rehydration therapy for children with gastroenteritis: a meta-analysis of randomized controlled trials. Arch Pediatr Adolesc Med (2004) 2.03
Pediatricians' attitudes toward randomized controlled trials involving children. J Pediatr (2002) 2.01
Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clin Chem Lab Med (2015) 1.98
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 1.98
Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence? Mayo Clin Proc (2002) 1.97
When should a new test become the current reference standard? Ann Intern Med (2008) 1.95